[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-349557-105":3,"detail-sidebar-cat-0-en-105":73,"doc-detail-349557-en":123},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":66,"head_meta":68,"extra_data":70,"updated_unix":72},105,"en","epigenomic-modifications-define-chromatin-states-to-regulate-cell-free-dna-fragmentomics","Epigenomic modifications define chromatin states to regulate cell-free DNA fragmentomics","","Epigenomic modifications regulate the fragmentation patterns of plasma circulating cell-free DNA (cfDNA), which are promising biomarkers for cancer detection and tumor-origin tracing. The study links cfDNA fragmentomic features to epigenetic marks and partitions the genome into chromatin states using histone modification signals. Associations are supported by histone-modifier perturbation experiments, showing chromatin organization as a key driver of cfDNA fragmentation. Transposon element (TE) fragmentomic features outperform genome-wide metrics for cancer diagnosis. An AI model, TEANA, uses a small TE feature set for pan-cancer detection and tumor-origin prediction across independent cohorts.",{"@graph":14,"@context":65},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/epigenomic-modifications-define-chromatin-states-to-regulate-cell-free-dna-fragmentomics/349557/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/epigenomic-modifications-define-chromatin-states-to-regulate-cell-free-dna-fragmentomics/349557.png","ImageObject",300,407,{"name":42,"@type":43},"dhado","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-29","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",14,{"@type":57,"mainEntity":58},"FAQPage",[59],{"name":60,"@type":61,"acceptedAnswer":62},"What is TEANA and how does it work for pan-cancer detection?","Question",{"text":63,"@type":64},"TEANA is an AI-empowered model that uses a small set of TE fragmentomic features to perform robust pan-cancer detection and tumor-origin prediction across independent cohorts.","Answer","https://schema.org",{"og:url":32,"og:type":67,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":69,"canonical":32},"index,follow",{"doc_id":71,"site_id":7},349557,1790162230,{"code":4,"msg":74,"data":75},"success",[76,80,84,88,93,98,103,107,112,115,119],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":77,"show_sort_weight":78,"slug":79},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":81,"show_sort_weight":82,"slug":83},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Exam",70,"exam",{"id":89,"doc_module":4,"doc_module_name":25,"category_name":90,"show_sort_weight":91,"slug":92},5,"Comic",60,"comic",{"id":94,"doc_module":4,"doc_module_name":25,"category_name":95,"show_sort_weight":96,"slug":97},6,"Technology",50,"technology",{"id":99,"doc_module":4,"doc_module_name":25,"category_name":100,"show_sort_weight":101,"slug":102},7,"Healthcare",40,"healthcare",{"id":104,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":105,"slug":106},8,30,"research-report",{"id":108,"doc_module":4,"doc_module_name":25,"category_name":109,"show_sort_weight":110,"slug":111},9,"Religion & Spirituality",20,"religion-spirituality",{"id":110,"doc_module":4,"doc_module_name":25,"category_name":113,"show_sort_weight":110,"slug":114},"World Cup","world-cup",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":116,"slug":118},10,"Lifestyle","lifestyle",{"id":120,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":89,"slug":122},19,"General","general",{"code":4,"msg":74,"data":124},{"doc_id":71,"user_id":125,"nickname":42,"user_avatar":126,"doc_module":4,"category_id":104,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":127,"file_id":128,"file_url":129,"file_type":130,"file_size":131,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":132,"language":133,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":134,"faqs":135,"seo_title":136,"seo_description":12,"update_tm":137,"read_time":138,"preview_page_count":33,"preview_urls":139},5909893218464,"https://ap-avatar.wpscdn.com/davatar_085a072bc5b1113ac321206ff7593b45","Article [https://doi.org/10.1038/s41467-026-75640-2](https://doi.org/10.1038/s41467-026-75640-2)  \nEpigenomic modiﬁcations deﬁne chromatin states to regulate cell-free DNA fragmentomics  \nReceived: 5 August 2025  \n\n| Accepted: 2 July 2026 |\n| --- |\n| |\n| Check for updates |\n\nFanglei Gong (龚芳雷)1,2,3,10, Yuqi Pan (潘裕琦)1,2,3,10, Huizhen Lin (林惠珍)1,2,3,10, Yunyun An (安昀昀)3, Mengqi Yang (杨梦琦)3,4, Xiaoyi Liu (刘晓懿)1,2,3,  \nYunxia Bai (白云霞)3, Zhenyu Zhang (张震宇)3, Bianbian Tang (唐变变)3,5, Kun Zhang (张昆)6, Xin Zhao (赵新)6, Yu Zhao (赵喻)7, Changzheng Du (杜长征)8, Xuetong Shen (申雪桐)9  & Kun Sun (孙坤)1,3   \nPlasma cell-free DNA (cfDNA) fragmentomics offer promising cancer biomarkers, but their molecular regulation remains elusive. Here, we investigate the role of epigenomic modiﬁcations in cfDNA fragmentation. We identify strong correlations between cfDNA fragmentomic features and various epigenetic marks measured in cfDNA. We further segment the genome into different chromatin states using histone modiﬁcation signals, revealing consistent associations with cfDNA fragmentomics. The association is further validated by histone modiﬁer perturbation experiments, conﬁrming chromatin organization as a key regulator of cfDNA fragmentation. CfDNA fragmentomic features associated with Transposon Elements (TEs) outperform genome-wide metrics in cancer diagnosis, reﬂecting cancer type-speciﬁc patterns. Leveraging these insights, we develop TEANA (Transposon Element Analysis in cfDNA), an AI-empowered model using a small set of TE fragmentomic features for pan-cancer detection and tumor-origin prediction, achieving robust performance across independent cohorts. Hence, chromatin states drive cfDNA fragmentation, and dysregulated TEs provide highly informative biomarkers for cancer diagnosis.  \nCirculating cell-free DNA (cfDNA) in plasma has been a subject of research for over 75 years. In healthy subjects, cfDNA predominantly originates from the hematopoietic system and liver1, whereas in cancer patients, tumors release cfDNA into the plasma. The analysis of cfDNAto assess the presence, progression, and molecular characteristics of tumors is commonly referred to as “cancer liquid biopsy”, a ﬁeld that  \nhas seen signiﬁcant advancements in translational medicine over the past decade. Topologically, most cfDNA molecules are small fragments, typically under 200 base pairs (bp), generated during cell death2. Recent studies have proven that the generation of fragmented cfDNA molecules is not a random process3–7. Distinctive features include a peak at 166 bp and a 10 bp periodicity below 143 bp8,9, as well  \n1Shenzhen Medical Academy of Research and Translation, Shenzhen, China. 2Westlake University, Hangzhou, China. 3Institute of Cancer Research, Shenzhen Bay Laboratory, Shenzhen, China. 4Department of Chemical and Biological Engineering, Division of Life Science, Hong Kong University of Science and Technology, Hong Kong, China. 5School of Science, Shenzhen Campus of Sun Yat-sen University, Sun Yat-sen University, Shenzhen, China. 6Hepato-Biliary Surgery Division, Shenzhen Third People’s Hospital, The Second Afﬁliated Hospital, Southern University of Science and Technology, Shenzhen, China. 7Molecular Cancer Research Center, School of Medicine, Shenzhen Campus of Sun Yat-sen University, Sun Yat-sen University, Shenzhen, China. 8Cancer Center, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua Medicine, Tsinghua University, Beijing, China. 9Institutes of Biomedical Sciences, School of Life Sciences, Inner Mongolia University, Hohhot, China. 10These authors contributed equally: Fanglei Gong, Yuqi Pan, Huizhen Lin.  \ne-mail: [snowshen@mac.com](snowshen@mac.com); [sunkun@szbl.ac.cn](sunkun@szbl.ac.cn)  \nas biased end sequence usages10. The fragmentation patterns of cfDNA, referred to as “fragmentomics”, are frequently altered in cancer, making them promising biomarkers for cancer diagnosis and tumor origin tracing11–16. However, despite the sub","cbCaiuYFRGbosDJ8","https://ap.wps.com/l/cbCaiuYFRGbosDJ8","pdf",4312033,15,"English","# Introduction\n## Background of cfDNA and fragmentomics\n## Epigenomic regulation and chromatin biology\n# Epigenomic control of cfDNA fragmentation\n## Correlations with epigenetic marks\n## Chromatin state segmentation\n## Experimental validation via histone modifier perturbations\n# Transposon-driven biomarkers and AI modeling\n## TE fragmentomic features for diagnosis\n## TEANA model for pan-cancer detection and tumor-origin prediction","[{\"question\":\"What is TEANA and how does it work for pan-cancer detection?\",\"answer\":\"TEANA is an AI-empowered model that uses a small set of TE fragmentomic features to perform robust pan-cancer detection and tumor-origin prediction across independent cohorts.\"}]","Epigenomic modifications define chromatin states to regulate cell-free DNA fragmentomics | PDF",1790084312,38,[140,144,148,152],{"page_no":22,"url":141,"width":142,"height":143},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0a392d29a18cffdfb1d1d3b71b5bccb4.webp",983,1305,{"page_no":26,"url":145,"width":146,"height":147},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d49e59851fece2414c4c7f5fff4fe94d.webp",982,1304,{"page_no":30,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/bc91e2d9d965b370ea9a89b83244d43b.webp",981,1303,{"page_no":33,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fdd54f047f3551c6d10da282f37215eb.webp",980,1301]